Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Seeking Alpha8/19/2026Neutral
ARAY
Accuray IncorporatedNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$31.87M
P/E Ratio
—
EPS
$-0.40
Beta
1.39
52W High
$2.10
52W Low
$0.22
50-Day MA
$0.27
200-Day MA
$0.51
Dividend Yield
—
Profit Margin
-12.20%
Forward P/E
12.41
PEG Ratio
29.49
About Accuray Incorporated
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
Fundamentals
| Revenue (TTM) | $401.95M |
| Gross Profit (TTM) | $111.45M |
| EBITDA | $-2.33M |
| Operating Margin | 6.21% |
| Return on Equity | -80.10% |
| Return on Assets | -1.40% |
| Revenue/Share (TTM) | $3.28 |
| Book Value | $0.35 |
| Price-to-Book | 0.76 |
| Price-to-Sales (TTM) | 0.08 |
| EV/Revenue | 0.435 |
| EV/EBITDA | 26.28 |
| Quarterly Earnings Growth (YoY) | -96.20% |
| Quarterly Revenue Growth (YoY) | -20.90% |
| Shares Outstanding | $119.44M |
| Float | $113.73M |
| % Insiders | 4.36% |
| % Institutions | 64.49% |
Historical Volatility
HV 10-Day
44.38%
HV 20-Day
75.01%
HV 30-Day
110.26%
HV 60-Day
100.78%
HV Rank
—
Volatility is currently contracting
Latest News
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
MADISON, Wis., Aug. 19, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026.
PRNewsWire8/19/2026Neutral
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to advance the strategic priorities in its recently announced transformation plan focused on sustainable, profitable growth.
PRNewsWire8/12/2026Neutral
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
MADISON, Wis., Aug. 5, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a conference call hosted by company management at 1:30 p.m.
PRNewsWire8/5/2026Neutral
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.
PRNewsWire5/29/2026Neutral
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.
PRNewsWire5/15/2026Neutral
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Seeking Alpha5/7/2026Neutral
Accuray Reports Fiscal 2026 Third Quarter Financial Results
MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.
PRNewsWire5/6/2026Neutral
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m.
PRNewsWire4/22/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ARAY and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026